European Journal of Clinical Investigation

Papers
(The H4-Index of European Journal of Clinical Investigation is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
137
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease101
Issue Information85
Impact of sirolimus on long‐term adverse cardiovascular outcomes in kidney transplant recipients: A nationwide cohort study81
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?77
Correction to ‘Association Between Exposure to Air Pollution and Blood Lipids in the General Population of Spain’75
Effects of glucagon‐like PEPTIDE‐1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META‐analysis67
Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease48
rFVIII‐Fc in severe haemophilia A: The incentive switch in case of high risk of joint bleedings46
Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis43
Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease41
Clinical use of controlled oxygenated rewarming of kidney grafts prior to transplantation by ex vivo machine perfusion. A pilot study39
Circ_0021087 acts as a miR‐184 sponge and represses gastric cancer progression by adsorbing miR‐184 and elevating FOSB expression39
Role of PERK‐mediated pathway in the effect of mild hypothermia after cerebral ischaemia/reperfusion39
Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives36
Clinical predictors of late SARS‐CoV‐2 positivity in Italian internal medicine wards36
Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function34
New insights into Covid‐19 disease. Apo‐A1 antibodies are generated after mRNA Covid‐19 vaccination and after Covid‐19 infection34
Combination therapy with an SGLT‐2 inhibitor and finerenone in DKD: Are we there yet?33
Seasonal vitamin D levels and lupus low disease activity state in systemic lupus erythematosus33
Human blood metabolites and risk of severe COVID‐19: A Mendelian randomization study33
Adipocyte maturation impacts daunorubicin disposition and metabolism32
Progress and challenges in the symbiosis of AI with science and medicine31
ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function30
Issue Information29
Clinical implications of vascular dysfunction in acute and convalescent COVID‐19: A systematic review29
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS‐CoV‐2 variants29
The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections29
The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial28
Social determinants of health and cardiovascular outcomes in patients with heart failure28
0.14512395858765